These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 17600908

  • 1. Treatment of Kawasaki disease.
    Taddio A, Rosé CD.
    N Engl J Med; 2007 Jun 28; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract] [Full Text] [Related]

  • 2. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
    Miura M, Ohki H, Yoshiba S, Ueda H, Sugaya A, Satoh M, Yamagishi H.
    Arch Dis Child; 2005 Oct 28; 90(10):1096-7. PubMed ID: 16177169
    [No Abstract] [Full Text] [Related]

  • 3. Revisiting steroids in the primary treatment of acute Kawasaki disease.
    Burns JC.
    J Pediatr; 2006 Sep 28; 149(3):291-2. PubMed ID: 16939734
    [No Abstract] [Full Text] [Related]

  • 4. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 28; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
    N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
    [Abstract] [Full Text] [Related]

  • 6. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST.
    J Pediatr; 2003 Jun 15; 142(6):601-3. PubMed ID: 12838185
    [No Abstract] [Full Text] [Related]

  • 7. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S.
    Nihon Rinsho; 2008 Feb 15; 66(2):338-42. PubMed ID: 18265457
    [Abstract] [Full Text] [Related]

  • 8. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
    Wang HW.
    Zhonghua Er Ke Za Zhi; 2006 May 15; 44(5):337-8. PubMed ID: 16780708
    [No Abstract] [Full Text] [Related]

  • 9. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G, Pardeo M, Rigante D.
    Eur Rev Med Pharmacol Sci; 2007 May 15; 11(5):301-8. PubMed ID: 18074939
    [Abstract] [Full Text] [Related]

  • 10. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M.
    Pediatrics; 2012 Jan 15; 129(1):e17-23. PubMed ID: 22144699
    [Abstract] [Full Text] [Related]

  • 11. [Immunoglobulin in suspected Kawasaki disease].
    García Soblechero E, Gómez Santos E, Domínguez Quintero ML, González Vila L.
    An Pediatr (Barc); 2010 Sep 15; 73(3):151-2. PubMed ID: 20605119
    [No Abstract] [Full Text] [Related]

  • 12. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M.
    J Cardiol; 2009 Feb 15; 53(1):15-9. PubMed ID: 19167633
    [Abstract] [Full Text] [Related]

  • 13. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
    Hung JJ, Chiu CH.
    Ann Trop Paediatr; 2004 Mar 15; 24(1):89-93. PubMed ID: 15005973
    [Abstract] [Full Text] [Related]

  • 14. Resistant Kawasaki disease.
    Nachiappan J, May M, Hawker RE, Hong P.
    J Paediatr Child Health; 2004 Mar 15; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract] [Full Text] [Related]

  • 15. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA, Stephens I.
    Pediatr Infect Dis J; 2010 Oct 15; 29(10):978-9. PubMed ID: 20431427
    [Abstract] [Full Text] [Related]

  • 16. [Improving the diagnosis and therapy of Kawasaki disease].
    Du JB.
    Zhonghua Er Ke Za Zhi; 2006 May 15; 44(5):321-3. PubMed ID: 16780704
    [No Abstract] [Full Text] [Related]

  • 17. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC, Vincenti M, Darras JP, Lalande M, Rodière M, Filleron A.
    Arch Pediatr; 2012 Jul 15; 19(7):741-4. PubMed ID: 22652521
    [Abstract] [Full Text] [Related]

  • 18. The use of corticosteroid therapy in refractory Kawasaki patients.
    Al-Mayouf SM.
    Clin Rheumatol; 2004 Feb 15; 23(1):11-3. PubMed ID: 14749974
    [Abstract] [Full Text] [Related]

  • 19. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T, Inoue Y, Morikawa A.
    Nihon Rinsho; 2008 Feb 15; 66(2):332-7. PubMed ID: 18260333
    [Abstract] [Full Text] [Related]

  • 20. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr 15; 11(4):318-21. PubMed ID: 19374823
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.